A blockbuster gene-editing tool has been linked to cancer — here"s how worried you should be
American Cancer Society/Getty Images Bold headlines linking blockbuster gene-editing tool CRISPR to cancer sent stocks in companies trying to bring the technology to medicine tumbling. But scientists who study the technique sa.....»»
A blockbuster gene editing tool could cause more damage than experts thought
Bobby Yip/Reuters A new study has concluded that genetic editing tool, CRISPR-Cas9, can cause significantly greater havoc than exp.....»»
Cancer research firm pledged 200 jobs in Raleigh. Now, it says operations are ramping up.
Two years after pledging to bring 200 high-paying jobs to Raleigh, a French gene editing firm is getting ready to start pumping out product from North Carolina......»»
When Will Gene Editing Help Humans? This Investor Says It’s Already Happening
Startup Tmunity is now in clinical trials with a cancer gene-killing treatment. The news came at the Fortune Brainstorm Health conference. Technology has long infused health care with inspiration and hope. Th.....»»
Brainstorm Health: AI and Old Drugs, Gene Editing Registry, AbbVie Cancer Drug
Brainstorm Health Daily.....»»
Brainstorm Health: Alex Trebek Cancer, China Gene Editing Rules, Gilead Shakeup
Brainstorm Health Daily: March 7, 2019 Good afternoon, readers. Busy times around here with a magazine deadline looming, so it’ll have to be a short one from me today. One note/mea cul.....»»
A Third Of The Great Barrier Reef Is Gone—Can Gene Editing Help Preserve The Rest?
By using a tool known as CRISPR-Cas9, scientists may be able to identify corals that are genetically predisposed to survive as the climate changes around them......»»
Scientists can use CRISPR to edit genes. Should they?
Bill Whitaker reports on the gene-editing tool this week on 60 Minutes. The debate over how to use it is playing out in labs around the world.....»»
CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing
Don't mess with mother nature.. or crowded longs! Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the po.....»»
CRISPR-related stocks sink after report that gene-editing technology might cause cancer
Shares of gene-therapy companies sank in active trade Monday, after a STAT report that editing a cell’s genome with CRISPR/Cas9 technology might cause cancer......»»
Scientists Just Found a Novel, Cheap Way to Use CRISPR Gene Editing to Fight Cancer
The CRISPR research was backed by Sean Parker's cancer immunotherap.....»»
Chinese Gene-Editing Trial Loses Track of Patients, Alarming Technology"s Inventors
A gene-editing trial in China lost touch with cancer patients whose DNA was altered, alarming some Western scientists who say subjects should be monitored for many years......»»
Will March Inflation Data Break Tech Rally"s Back? Why Wall Street"s "Dean Of Valuation" And Gene Munster Are Worried, But Paul Krugman And Other Economists Are Not
Economists generally predict a slight slowdown in the month-over-month inflation rate, with consumer prices and the core reading potentially rising by 0.3% in March compared to 0.4% in February. read more.....»»
Why Precision BioSciences Stock Is Trading Higher Today
Precision BioSciences (NASDAQ: DTIL) shares are trading higher after the company reported its ARCUS platform showed a promising gene editing approach for transthyretin amyloidosis. read more.....»»
Precision BioSciences Shares Move Higher As ARCUS Platform Shows Promising Gene Editing Approach For Transthyretin Amyloidosis
read more.....»»
Genprex in-licenses gene therapy technologies for lung cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Homology Medicines presents data on in vivo nuclease-free gene editing
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia
Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»
Uniqure"s Hemophilia B Gene Therapy Unlikely To Be Cause Of Liver Cancer Reported In One Patient
Uniqure NV (NASDAQ: QURE) has read more.....»»
: Biotech stocks are a buy — especially these 18 picks
The sector's recent pullback offers an chance to get into exciting areas of biotech research like gene editing and oncology at better prices......»»
Origin Agritech utilized gene editing technology to create new corn traits
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»